Skip to main content
. 2021 Aug 10;12:713686. doi: 10.3389/fpsyt.2021.713686

Figure 2.

Figure 2

Scatter plots showing differences across visit in opioid craving scores in participants receiving active vs. sham treatment with unilateral transcranial photobiomodulation from mixed model analysis, N = 39 with 20 actives.